Company profile
BIOCRYST PHARMACEUTICALS INC
NASDAQ:BCRXBiotechnology: Biological Products (No Diagnostic Substances)
Drug pipeline (7)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ORLADEYO | approved | $116.3MQ3 2024 | 0 | — |
| RAPIVAB | approved | — | 10 | approved |
| AVORALSTAT | phase3 | — | 6 | completed, terminated |
| BEROTRALSTAT | phase3 | — | 9 | active |
| FORODESINE | phase2 | — | 2 | no active trials |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (53)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02303626 | phase2_3 | completed | 2014-12-17 | 2016-01-01 | BioCryst Pharmaceuticals | 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks |
| NCT03136237 | phase1 | completed | 2017-02-17 | 2017-08-15 | BioCryst Pharmaceuticals | A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions |
| NCT03472040 | phase2_3 | completed | 2018-02-16 | 2022-04-27 | BioCryst Pharmaceuticals | A Long Term Safety Study of BCX7353 in Hereditary Angioedema |
| NCT04702568 | phase2 | terminated | 2020-12-18 | 2023-10-04 | BioCryst Pharmaceuticals | A Long-Term Safety Study of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| NCT02319772 | phase1 | completed | 2014-12-01 | 2016-03-01 | BioCryst Pharmaceuticals | A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430 |
FDA applications (3)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 219776 | 2025-12-11 | NDA | BIOCRYST PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| NDA 214094 | 2020-12-03 | NDA | BIOCRYST PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| NDA 206426 | 2014-12-19 | NDA | BIOCRYST PHARMACEUTICALS INC | |||||
Loading… | ||||||||